REFERENCES
Braida, D. Pozzi, M. and Sala, M., 2000. CP 55,940 protects against ischemia-induced electroencephalo-graphic flattening and hyperlocomotion in Mongolian gerbils. Neuroscience Letters, 296( 2–3), 69–72
Brown P., 2002. Drug therapy in human and experimental transmissible spongiform encephalopathy. Neurology. 58(12), 1720–1725
Cuajungco, M.P., Faget, K.Y., Huang, X., Tanzi, R.E. and Bush, A.I., 2000. Metal chelation as a potential therapy for Alzheimer's disease. Annals of the New York Academy of Sciences, 920, 292–304
Melov S., 2002}, ‘... and C is for Clioquinol’–the AbetaCs of Alzheimer's disease. Trends in Neurosciences, 25(3), 121–123
Sala, M., Leone, M.P., Lampugnani, P., Matturri, L. and Gori, E., 1997. Polydeoxyribonucleotide (defibro-tide) protects against post-ischemic behavioral, electroencephalographic and neuronal damage in the gerbil. European Journal of Pharmacology, 328(2–3), 143–152
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ponti, W., Sala, M., Pollera, C. et al. In vivo Model for the Evaluation of Molecules Active Towards Transmissible Spongiform Encephalopathies. Vet Res Commun 28 (Suppl 1), 307–310 (2004). https://doi.org/10.1023/B:VERC.0000045433.45346.1c
Issue Date:
DOI: https://doi.org/10.1023/B:VERC.0000045433.45346.1c